Semaglutide and colchicine demonstrated anti-arrhythmic and anti-remodeling effects in rats with post-myocardial infarction heart failure, limiting atrial fibrillation substrate progression.
Do semaglutide and colchicine reduce atrial remodeling and arrhythmias in rats with reduced ejection fraction after myocardial infarction?
Semaglutide and colchicine demonstrate anti-arrhythmic and anti-remodeling effects in a rat model of post-MI heart failure, suggesting multiple targetable pathways for limiting atrial fibrillation substrate progression.
Absolute Event Rate: 0% vs 0%
In the post-MI HF setting, both drugs demonstrated anti-arrhythmic and anti-remodeling effects. Their differential actions suggest that multiple pathways can be targeted to limit AF substrate progression.
Levi et al. (Fri,) reported a other. Semaglutide and colchicine demonstrated anti-arrhythmic and anti-remodeling effects in rats with post-myocardial infarction heart failure, limiting atrial fibrillation substrate progression.